X4 Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.About XFOR
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. The firm is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi.
CEOPaula S. Ragan, PhD
CEOPaula S. Ragan, PhD
Employees143
Employees143
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2010
Founded2010
Employees143
Employees143
XFOR Key Statistics
Market cap68.69M
Market cap68.69M
Price-Earnings ratio-0.21
Price-Earnings ratio-0.21
Dividend yield—
Dividend yield—
Average volume572.57K
Average volume572.57K
High today$3.37
High today$3.37
Low today$3.04
Low today$3.04
Open price$3.20
Open price$3.20
Volume664.90K
Volume664.90K
52 Week high$26.83
52 Week high$26.83
52 Week low$1.35
52 Week low$1.35
XFOR News
Seeking Alpha 21h
X4 Pharmaceuticals to reduce 50% of workforceHealthcare X4 Pharmaceuticals to reduce 50% of workforce Sep. 17, 2025 7:33 AM ET X4 Pharmaceuticals, Inc. (XFOR) Stock By: Preeti Singh, SA News Editor 5 Share...
TipRanks 21h
X4 Pharmaceuticals Announces Major Strategic RestructuringElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 21h
X4 Pharmaceuticals announces restructuring, 50% reduction in workforceX4 Pharmaceuticals (XFOR) announced a strategic restructuring designed to sharpen operational focus and align resources with the Company’s long-term strategy to...
People also own
Based on the portfolios of people who own XFOR. This list is generated using Robinhood data, and it’s not a recommendation.